Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study

Simone Garcovich, Clara De Simone, Giovanni Delogu, Alberto Ruggeri, Magda D'Agostino, Fausta Ardito, G. Fadda

Risultato della ricerca: Contributo in rivistaArticolo in rivista

41 Citazioni (Scopus)

Abstract

Psoriasis patients who are treated with tumour necrosis factor (TNF)-alpha antagonists are at increased risk of reactivation of latent tuberculosis infection (LTBI) and should be adequately screened and monitored during active treatment.
Lingua originaleEnglish
pagine (da-a)1572-1576
Numero di pagine5
RivistaJournal of the European Academy of Dermatology and Venereology
Volume26
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • tbc

Fingerprint

Entra nei temi di ricerca di 'Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study'. Insieme formano una fingerprint unica.

Cita questo